AST SpaceMobile Shares Climb on Market Approval News Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment Sensex Surges Over 850 Points Nifty Approaches 24000 as IranUS Deal Hopes Drive Crude Oil Plunge Baird Raises Price Target on RideNow Group RDNW on Strong SameStore Sales Performance CMS Energy Analyst Estimates Market Sentiment and Ratings Overview Mexico Agrees to Host Irans World Cup Squad Amid USIran Tensions Says President Sheinbaum SPRB Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Sentiment HUMA Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher SVCO Q1 2026 Earnings EPS Beat Signals Cost Discipline Amidst Revenue Uncertainty MPLT Q1 2026 Earnings EPS Miss of 20 Amid No Revenue Stock Declines TFII Q1 2026 Earnings EPS Beats Estimates by Double Digits CNI Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Operations MGR Preferreds Hold Steady Near Midpoint of Trading Range Simon Property Group SPG Holds Near 204 Amid Quiet Trading Key Levels in Focus Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone Gold Resource Corporation GORO Surges on Bullish Momentum Eyes Resistance at 144 Burning Rock Biotech BNR Plunges 15 as Selling Pressure Intensifies Morgan Stanley Lowers Equinor Price Target Following FirstQuarter Results BBGI Q4 2025 Earnings Significant Loss Reported Stock Rises 415 AGM Group Holdings AGMH Surges 124 as Momentum Builds Toward Key Resistance BBWI Q1 2026 Earnings EPS Surges Past Estimates with 1328 Surprise Tenaya Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Steady Pipeline Progress FOR Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Gains 36 Lantheus Holdings LNTH Q1 2026 Earnings EPS Surges Past Estimates as Radiopharmaceutical Momentum Continues KNSA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Product Growth INVH Q1 2026 Earnings Strong EPS Beat Fails to Boost Sentiment as Stock Edges Lower Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn